Bank
, Pharmacotherapeuticsn forn Advancedn Practicen Nursen Prescribersn 5thn Editionn Woon Robinsonn Testn
Bank
Pharmacotherapeutics n
forn Advancedn Practicen Nursen Prescribersn 5thn Editionn Woon Robinsonn Testn Bank
Chaptern 1.n ThenRolenofn thenNursen
PractitionernMultiplen Choice
Identifyn then choicen thatn bestn completesn then statementn orn answersn then question.
n nn 1.n n Nursen practitionern prescriptiven authorityn isn regulatedn by:
1. Then Nationaln Counciln ofn Staten Boardsn ofn Nursing
2. Then U.S.n Drugn Enforcementn Administration
3. Then Staten Boardn ofn Nursingn forn eachn state
4. Then Staten Boardn ofn Pharmacy
n nn 2.n Then benefitsn ton then patientn ofn havingn ann Advancedn Practicen Registeredn Nursen (APRN)n
prescriberinclude:
n
1. Nursesn known moren aboutn Pharmacologyn thann othern prescribersn becausen theyn taken
itnbothn inn theirn basicn nursingn programn andn inn theirn APRNn program.
2. Nursesn caren forn then patientn fromn an holisticn approachn andn includen then patientn in
decisionn makingn regardingn theirn care.
3. APRNsn aren lessn likelyn ton prescriben narcoticsn andn othern controlledn substances.
4. APRNsn aren ablen ton prescriben independentlyninn alln states,n whereasn an
physician’snassistantn needsn ton haven an physiciann supervisingn theirn practice.
n nn 3.n Clinicaln judgmentn inn prescribingn includes:
1. Factoringn inn then costn ton then patientn ofn then medicationn prescribed
2. Alwaysn prescribingn then newestn medicationn availablen forn then diseasen process
3. Handingn outn drugn samplesn ton poorn patients
4. Prescribingn alln genericn medicationsn ton cutn costs
n nn 4.n Criterian forn choosingn ann effectiven drugn forn an disordern include:
1. Askingn then patientn whatn drugn theyn thinkn wouldn workn bestn forn them
2. Consultingn nationallyn recognizedn guidelinesn forn diseasen management
3. Prescribingn medicationsn thatn aren availablen asn samplesn beforen writingn an prescription
4. Followingn U.S.n Drugn Enforcementn Administrationn guidelinesn forn prescribing
n nn 5.n Nursen practitionern practicen mayn thriven undern health-caren reformn becausen of:
1. Then demonstratedn abilityn ofn nursen practitionersn ton controln costsn andn improven
patientoutcomes
n
2. Then factn thatn nursen practitionersn willn ben ablen ton practicen independently
3. Then factn thatn nursen practitionersn willn haven fulln reimbursementn undern health-
carenreform
4. Then abilityn ton shiftn accountabilityn forn Medicaidn ton then staten level
,Pharmacotherapeuticsn forn Advancedn Practicen Nursen Prescribersn 5thn Editionn Woon Robinsonn Testn
Bank
, Pharmacotherapeuticsn forn Advancedn Practicen Nursen Prescribersn 5thn Editionn Woon Robinsonn Testn
Bank
Chaptern 1.n Then Rolen ofn then Nursen
PractitionernAnswern Section
MULTIPLEn CHOICE
1. ANS:n n n 3 PTS:n 1
2. ANS:n n n 2 PTS:n 1
3. ANS:n n n 1 PTS:n 1
4. ANS:n n n 2 PTS:n 1
5. ANS:n n n 1 PTS:n 1
Chaptern 2.n Reviewn ofn Basicn Principlesn ofn
PharmacologynMultiplen Choice
Identifyn then choicen thatn bestn completesn then statementn orn answersn then question.
n nn 1.n An patient’sn nutritionaln intaken andn laboratoryn resultsn reflectn hypoalbuminemia.n Thisn isn criticaln
tonprescribingn because:
1. Distributionn ofn drugsn ton targetn tissuen mayn ben affected.
2. Then solubilityn ofn then drugn willn notn matchn then siten ofn absorption.
3. Theren willn ben lessn freen drugn availablen ton generaten ann effect.
4. Drugsn boundn ton albuminn aren readilyn excretedn byn then kidneys.
n nn 2.n Drugsn thatn haven an significantn first-passn effect:
1. Mustn ben givenn byn then enteraln (oral)n routen only
2. Bypassn then hepaticn circulation
3. Aren rapidlyn metabolizedn byn then livern andn mayn haven littlen ifn anyndesiredn action
4. Aren convertedn byn then livern ton moren activen andn fat-solublen forms
n nn 3.n Then routen ofn excretionn ofn an volatilen drugn willn likelyn ben the:
1. Kidneys
2. Lungs
3. Bilen andn feces
4. Skin
n nn 4.n Medroxyprogesteronen (Depon Provera)n isn prescribedn intramuscularlyn(IM)n ton createn an
storagenreservoirn ofn then drug.n Storagen reservoirs:
1. Assuren thatn then drugn willn reachn itsn intendedn targetn tissue
2. Aren then reasonn forn givingn loadingn doses
3. Increasen then lengthn ofn timen an drugn isn availablen andn active
4. Aren mostn commonn inn collagenn tissues
n nn 5.n Then NPn choosesn ton given cephalexinn everyn 8n hoursn basedn onn knowledgen ofn then drug’s:
1. Propensityn ton gon ton then targetn receptor
2. Biologicaln half-life
3. Pharmacodynamics
4. Safetyn andn siden effects